当前位置:首页 - 行情中心 - 万孚生物(300482) - 财务分析 - 利润表

万孚生物

(300482)

  

流通市值:67.05亿  总市值:73.13亿
流通股本:4.29亿   总股本:4.68亿

利润表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、营业总收入1,568,892,198.991,038,506,474.79581,742,751.092,086,830,072.65
  营业收入1,568,892,198.991,038,506,474.79581,742,751.092,086,830,072.65
二、营业总成本1,453,233,686.87924,188,328.32491,970,446.342,249,566,528.36
  营业成本590,386,936.54378,751,665.98213,831,615.49897,853,120.8
  税金及附加21,102,775.4115,739,983.878,280,208.5815,022,930.25
  销售费用424,293,694.03279,377,823.88137,420,185.44658,840,553.03
  管理费用116,656,184.1478,066,328.0240,391,365.18299,448,333.58
  研发费用205,797,589.6137,847,320.8573,647,885.55336,700,613.8
  财务费用94,996,507.1534,405,205.7218,399,186.141,700,976.9
  其中:利息费用67,325,925.4314,683,761.077,448,942.4731,138,596.21
  其中:利息收入5,389,660.343,914,088.941,627,195.867,673,544.63
三、其他经营收益
  加:公允价值变动收益12,664,831.5613,030,142.946,747,243.2813,639,950.87
  加:投资收益19,917,144.867,683,449.313,137,777.5739,786,048.52
  资产处置收益00-318,789.99
  资产减值损失(新)-7,109,529.340-1,000-23,709,931.39
  信用减值损失(新)-3,739,964.05-4,060,710.91-7,893,474.9-951,533.16
  其他收益21,680,021.2311,596,576.446,154,805.5923,237,287.78
四、营业利润159,071,016.38142,567,604.2597,917,656.29-110,415,843.1
  加:营业外收入1,507,121.741,158,445.95765,368.732,898,040.14
  减:营业外支出10,148,994.573,172,265.321,504,483.057,175,503.97
五、利润总额150,429,143.55140,553,784.8897,178,541.97-114,693,306.93
  减:所得税费用12,263,323.8815,398,520.8211,056,073.74-45,034,833.47
六、净利润138,165,819.67125,155,264.0686,122,468.23-69,658,473.46
(一)按经营持续性分类
  持续经营净利润138,165,819.67125,155,264.0686,122,468.23-69,588,874.23
  终止经营净利润----69,599.23
(二)按所有权归属分类
  归属于母公司股东的净利润133,879,690.53122,522,800.4484,399,549.76-63,024,899.74
  少数股东损益4,286,129.142,632,463.621,722,918.47-6,633,573.72
  扣除非经常损益后的净利润85,854,491.8489,179,567.1666,708,002.52-12,969,757.16
七、每股收益
  (一)基本每股收益0.290.260.18-0.13
  (二)稀释每股收益0.290.260.18-0.13
八、其他综合收益-17,212,215.47,017,702.4618,116,871.3342,498,484.27
  归属于母公司股东的其他综合收益-17,212,215.47,017,702.4618,116,871.3342,498,484.27
九、综合收益总额120,953,604.27132,172,966.52104,239,339.56-27,159,989.19
  归属于母公司股东的综合收益总额116,667,475.13129,540,502.9102,516,421.09-20,526,415.47
  归属于少数股东的综合收益总额4,286,129.142,632,463.621,722,918.47-6,633,573.72
公告日期2026-10-282026-08-242026-04-232026-04-23
审计意见(境内)标准无保留意见
TOP↑